BioCentury | Oct 8, 2020
Finance

Hillhouse’s Genor tops off busy year with IPO, plans to ‘transform’ pipeline

...completed its series B, bringing in new investors Temasek, CR-CP Life Science Fund, Haitong Capital and Cavenham PE...
BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...by existing investor Hillhouse Capital. New investors Temasek, CR-CP Life Science Fund, Haitong Capital and Cavenham PE...
Items per page:
1 - 2 of 2
BioCentury | Oct 8, 2020
Finance

Hillhouse’s Genor tops off busy year with IPO, plans to ‘transform’ pipeline

...completed its series B, bringing in new investors Temasek, CR-CP Life Science Fund, Haitong Capital and Cavenham PE...
BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...by existing investor Hillhouse Capital. New investors Temasek, CR-CP Life Science Fund, Haitong Capital and Cavenham PE...
Items per page:
1 - 2 of 2